1. Academic Validation
  2. The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency

The molecular genetic basis of muscle phosphoglycerate mutase (PGAM) deficiency

  • Am J Hum Genet. 1993 Mar;52(3):472-7.
S Tsujino 1 S Shanske S Sakoda G Fenichel S DiMauro
Affiliations

Affiliation

  • 1 H. Houston Merritt Clinical Research Center for Muscular Dystrophy and Related Diseases, Department of Neurology, Columbia-Presbyterian Medical Center, New York, NY.
PMID: 8447317
Abstract

The glycolytic Enzyme phosphoglycerate mutase (PGAM) is a dimer, and mature human skeletal muscle contains almost exclusively the MM form of the Enzyme, PGAM-M. In 1981, we identified a patient with PGAM-M deficiency, and three additional patients have since been described. All presented with exercise intolerance, cramps, and myoglobinuria. We report two new patients with PGAM-M deficiency and describe the molecular lesions in five patients--four African-Americans and one Caucasian. Three patients were homozygous for an identical G-to-A transition converting an encoded Trp to an in-frame stop codon (codon 78). A fourth patient was heterozygous for this mutation and also carried an A-to-C mutation converting Glu to Ala (codon 89). The fifth patient, the only Caucasian, was homozygous for a different point mutation, a C-to-T mutation, converting Arg to Trp (codon 90).

Figures